138 related articles for article (PubMed ID: 11144542)
21. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.
Zeliadt SB; Etzioni RD; Penson DF; Thompson IM; Ramsey SD
Am J Med; 2005 Aug; 118(8):850-7. PubMed ID: 16084177
[TBL] [Abstract][Full Text] [Related]
22. The cost-effectiveness of early noninvasive ventilation for ALS patients.
Gruis KL; Chernew ME; Brown DL
BMC Health Serv Res; 2005 Aug; 5():58. PubMed ID: 16131401
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
[TBL] [Abstract][Full Text] [Related]
24. A retrospective evaluation of completion rates, total cost, and adverse effects for treatment of latent tuberculosis infection in a public health clinic in central massachusetts.
Young H; Wessolossky M; Ellis J; Kaminski M; Daly JS
Clin Infect Dis; 2009 Aug; 49(3):424-7. PubMed ID: 19548835
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan.
Maeda K; Shimbo T; Fukui T
J Med Screen; 2004; 11(2):97-102. PubMed ID: 15153326
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
Flaherman VJ; Porco TC; Marseille E; Royce SE
Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
[TBL] [Abstract][Full Text] [Related]
27. Latent tuberculosis infection in children: a call for revised treatment guidelines.
Finnell SM; Christenson JC; Downs SM
Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
[TBL] [Abstract][Full Text] [Related]
28. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
29. High participation rates are not necessary for cost-effective colorectal cancer screening.
Howard K; Salkeld G; Irwig L; Adelstein BA
J Med Screen; 2005; 12(2):96-102. PubMed ID: 15949121
[TBL] [Abstract][Full Text] [Related]
30. Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy.
Rubenstein JH; Inadomi JM; Brill JV; Eisen GM
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):312-8. PubMed ID: 17368230
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
Hassan C; Zullo A; Winn S; Morini S
Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
[TBL] [Abstract][Full Text] [Related]
32. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country.
Brassard P; Steensma C; Cadieux L; Lands LC
Pediatrics; 2006 Feb; 117(2):e148-56. PubMed ID: 16452324
[TBL] [Abstract][Full Text] [Related]
34. Extensively drug-resistant tuberculosis.
Cheruvu M; Bhadriraju S
N Engl J Med; 2008 Nov; 359(22):2390-1; author reply 2391. PubMed ID: 19051373
[No Abstract] [Full Text] [Related]
35. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
Kim JJ; Leung GM; Woo PP; Goldie SJ
J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
[TBL] [Abstract][Full Text] [Related]
36. [Critical evaluation of a cost-effectiveness analysis].
Sendi PP; Bucher HC; Steurer J
Praxis (Bern 1994); 1998 Dec; 87(49):1695-702. PubMed ID: 9887670
[No Abstract] [Full Text] [Related]
37. The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis.
Macintyre CR; Plant AJ; Hendrie D
Health Econ; 2000 Jul; 9(5):411-21. PubMed ID: 10903541
[TBL] [Abstract][Full Text] [Related]
38. Tuberculosis control in crisis: economic honesty and comparative effectiveness.
Dowdy D; Vassall A; Cobelens F
Int J Tuberc Lung Dis; 2012 Aug; 16(8):1131-2. PubMed ID: 22762428
[No Abstract] [Full Text] [Related]
39. [Ways of increasing the effectiveness of tuberculosis control].
Punga VV
Probl Tuberk; 1989; (2):3-6. PubMed ID: 2704708
[TBL] [Abstract][Full Text] [Related]
40. School-based screening for tuberculous infection. A cost-benefit analysis.
Mohle-Boetani JC; Miller B; Halpern M; Trivedi A; Lessler J; Solomon SL; Fenstersheib M
JAMA; 1995 Aug 23-30; 274(8):613-9. PubMed ID: 7637141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
